Health - Regional court rules in vaccine damage lawsuit against Biontech
The Rottweil Regional Court will announce a decision on Wednesday in the case against the coronavirus vaccine manufacturer Biontech. The plaintiff is a 58-year-old man. He accuses Biontech of causing him to become almost completely blind in his right eye as a result of a coronavirus vaccination. The man is demanding 150,000 euros in compensation from the Mainz-based company and a declaration that he must be compensated for all further damages.
According to presiding judge Torsten Hub, there are two options in the case. Either the court dismisses the man's claim with a judgment. However, the regional court can also decide on a so-called order to take evidence on the risk-benefit ratio. In this case, an expert report is commissioned to examine this relationship.
This is not the first trial of its kind in Germany. Nor is it the first decision by a court in this context. The Mainz-based company Biontech has so far refused to reach an amicable settlement.
Most recently, on November 16, the Düsseldorf Regional Court dismissed claims for damages and compensation for pain and suffering against two vaccine manufacturers for alleged damage caused by coronavirus vaccinations as unfounded. Two women and a man from Kaarst, Meerbusch and Düsseldorf had filed a lawsuit against the Mainz-based vaccine manufacturer Biontech. They are claiming a total of almost 500,000 euros in compensation for pain and suffering and over 30,000 euros in material damages due to alleged permanent damage caused by the coronavirus vaccination with the active ingredient Comirnaty.
Read also:
- Will he be convicted as Jutta's murderer after 37 years?
- He also wanted to kill his cousin
- With live stream! Gawkers film dying man
- Is Saarland threatened with economic collapse?
- The case in Rottweil is not an isolated incident in Baden-Württemberg, as Germany has seen several similar lawsuits against Biontech due to alleged side effects from their coronavirus vaccine.
- The Rottweil Regional Court's decision will add to the growing body of legal precedents surrounding coronavirus vaccine damage claims in Germany.
- Meanwhile, in Rhineland-Palatinate, another regional court recently dismissed claims for damages against Biontech related to coronavirus vaccinations.
- The global coronavirus pandemic has led to an unprecedented number of vaccine rollouts, raising questions about vaccine safety and accountability across Europe and beyond.
- In Germany, the Regional Court of Rottweil's decision could potentially impact the process for compensating individuals who believe they have suffered damages as a result of coronavirus vaccinations.
- As Germany continues to grapple with the ongoing Covid-19 pandemic and its impact on public health, legal cases like these in Rottweil and other cities will contribute to shaping the nation's response to the Coronavirus and vaccine safety concerns.
Source: www.stern.de
